{"product_id":"patient-derived-tumor-xenograft-models-promise-potential-and-practice-pdf","title":"Patient Derived Tumor Xenograft Models, Promise, Potential and Practice","description":"\u003cp\u003e\u003cstrong\u003ePatient Derived Tumor Xenograft Models, Promise, Potential and Practice.pdf |\u003c\/strong\u003e\u003c\/p\u003e\u003cp\u003eCategory: Default\u003c\/p\u003e\u003cp\u003eDigital download (PDF).\u003c\/p\u003e\n\n\u003ch3\u003eTable of Contents\u003c\/h3\u003e\n\u003cdiv class=\"gvc-locked-preview\"\u003e\n  \u003cdiv class=\"gvc-locked-icon\"\u003e🔒\u003c\/div\u003e\n  \u003ch3\u003eSample Preview\u003c\/h3\u003e\n  \u003cp\u003eThe full PDF is available after purchase. Instant download. Lifetime access. Read on any device.\u003c\/p\u003e\n  \u003cp class=\"gvc-locked-meta\"\u003eTrusted by 4,000+ veterinary professionals worldwide.\u003c\/p\u003e\n\u003c\/div\u003e\n\n\u003cul\u003e\n  \u003cli\u003eContents (p.7)\u003c\/li\u003e\n  \u003cli\u003ePreface (p.27)\u003c\/li\u003e\n  \u003cli\u003e1 - PDX Models: History and Development (p.31)\u003c\/li\u003e\n  \u003cli\u003eREFERENCES (p.38)\u003c\/li\u003e\n  \u003cli\u003e2 - History of Mouse Cancer Models (p.43)\u003c\/li\u003e\n  \u003cli\u003eREFERENCES (p.50)\u003c\/li\u003e\n  \u003cli\u003e3 - Challenges and Limitations of Mouse Xenograft Models of Cancer (p.53)\u003c\/li\u003e\n  \u003cli\u003eREFERENCES (p.61)\u003c\/li\u003e\n  \u003cli\u003e4 - Tumor Heterogeneity (p.65)\u003c\/li\u003e\n  \u003cli\u003eREFERENCES (p.78)\u003c\/li\u003e\n  \u003cli\u003e5 - Immunodeficient Mice: The Backbone of Patient-Derived Tumor Xenograft Models (p.85)\u003c\/li\u003e\n  \u003cli\u003eREFERENCES (p.99)\u003c\/li\u003e\n  \u003cli\u003e6 - Humanized Mice and PDX Models (p.103)\u003c\/li\u003e\n  \u003cli\u003eREFERENCES (p.114)\u003c\/li\u003e\n  \u003cli\u003e1 - Regulations of Patient-Derived Xenografts (p.121)\u003c\/li\u003e\n  \u003cli\u003eREFERENCES (p.134)\u003c\/li\u003e\n  \u003cli\u003e2 - Acquisition and Storage of Clinical Samples to Establish PDX Models (p.137)\u003c\/li\u003e\n  \u003cli\u003eREFERENCES (p.146)\u003c\/li\u003e\n  \u003cli\u003e3 - Methodologies for Developing and Maintaining Patient-Derived Xenograft Mouse Models (p.147)\u003c\/li\u003e\n  \u003cli\u003eREFERENCES (p.160)\u003c\/li\u003e\n  \u003cli\u003e4 - Pathology of Patient-Derived Xenograft Tumors (p.163)\u003c\/li\u003e\n  \u003cli\u003eREFERENCES (p.174)\u003c\/li\u003e\n  \u003cli\u003e5 - Genetic Profiling of Tumors in PDX Models (p.177)\u003c\/li\u003e\n  \u003cli\u003eREFERENCES (p.186)\u003c\/li\u003e\n  \u003cli\u003e6 - Running a PDX Core Laboratory or a PDX Support Program (p.189)\u003c\/li\u003e\n  \u003cli\u003eREFERENCES (p.200)\u003c\/li\u003e\n  \u003cli\u003e7 - Veterinary Care (p.201)\u003c\/li\u003e\n  \u003cli\u003eREFERENCES (p.209)\u003c\/li\u003e\n  \u003cli\u003e8 - Occupational Health and Safety (p.215)\u003c\/li\u003e\n  \u003cli\u003eREFERENCES (p.227)\u003c\/li\u003e\n  \u003cli\u003e1 - Pediatric and Adult Brain Tumor PDX Models (p.233)\u003c\/li\u003e\n  \u003cli\u003eREFERENCES (p.241)\u003c\/li\u003e\n  \u003cli\u003e2 - Patient-Derived Xenograft Models of Prostate Tumors (p.245)\u003c\/li\u003e\n  \u003cli\u003eREFERENCES (p.253)\u003c\/li\u003e\n  \u003cli\u003e3 - Patient-Derived Xenograft Model of Pancreatic Cancer (p.257)\u003c\/li\u003e\n  \u003cli\u003eREFERENCES (p.267)\u003c\/li\u003e\n  \u003cli\u003e4 - Modeling Breast Cancer Heterogeneity With Patient-Derived Xenografts (p.271)\u003c\/li\u003e\n  \u003cli\u003eREFERENCES (p.283)\u003c\/li\u003e\n  \u003cli\u003e5 - Patient-Derived Xenograft Models of Ovarian\/Gynecologic Tumors (p.285)\u003c\/li\u003e\n  \u003cli\u003eREFERENCES (p.296)\u003c\/li\u003e\n  \u003cli\u003e6 - Patient-Derived Xenografts From Lung Cancer and Their Potential Applications (p.301)\u003c\/li\u003e\n  \u003cli\u003eREFERENCES (p.311)\u003c\/li\u003e\n  \u003cli\u003e7 - PDX Models of Colorectal Tumors (p.319)\u003c\/li\u003e\n  \u003cli\u003eREFERENCES (p.330)\u003c\/li\u003e\n  \u003cli\u003e8 - Patient-Derived Tumor Xenografts in Hematologic Disorders (p.333)\u003c\/li\u003e\n  \u003cli\u003eREFERENCES (p.358)\u003c\/li\u003e\n  \u003cli\u003e9 - Patient-Derived Xenografting of Human Melanoma (p.369)\u003c\/li\u003e\n  \u003cli\u003eREFERENCES (p.386)\u003c\/li\u003e\n  \u003cli\u003e10 - Advances in Organoid Culturing of Patient-Derived Tumors (p.393)\u003c\/li\u003e\n  \u003cli\u003eREFERENCES (p.400)\u003c\/li\u003e\n  \u003cli\u003e1 - Global Practices in PDX Programs (p.407)\u003c\/li\u003e\n  \u003cli\u003eREFERENCES (p.432)\u003c\/li\u003e\n  \u003cli\u003e2 - Role of Companies and Corporations in the Development and Utilization of PDX Models (p.437)\u003c\/li\u003e\n  \u003cli\u003eAPPENDIX 1. ADDITIONAL INFORMATION ON SOME COMPANIES PROVIDING AND SUPPORTING PDX MODEL DEVELOPMENT (p.452)\u003c\/li\u003e\n  \u003cli\u003eREFERENCES (p.454)\u003c\/li\u003e\n  \u003cli\u003e1 - Patient-Derived Tumor Xenograft: Present and Future Challenges and Applications (p.457)\u003c\/li\u003e\n  \u003cli\u003eREFERENCES (p.473)\u003c\/li\u003e\n  \u003cli\u003eIndex (p.481)\u003c\/li\u003e\n  \u003cli\u003e\u003cem\u003e... and 419 more chapters\u003c\/em\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\n\u003cdiv style=\"margin:20px 0;\"\u003e\n\u003ch3\u003ePreview This Book (First 20 Pages)\u003c\/h3\u003e\n\n\u003cp style=\"font-size:12px;color:#666;margin-top:4px;\"\u003eScroll through the preview above to see the first 20 pages of this book.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cp\u003e\u003cstrong\u003e🔗 Download Link:\u003c\/strong\u003e \u003c\/p\u003e","brand":"Global Vet \u0026 Co","offers":[{"title":"Default Title","offer_id":51248809607483,"sku":null,"price":200.0,"currency_code":"HKD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0948\/3062\/5083\/files\/patient-derived-tumor-xenograft-models-promise-potential-and-practice-pdf_HD.jpg?v=1780514452","url":"https:\/\/globalvetco.com\/products\/patient-derived-tumor-xenograft-models-promise-potential-and-practice-pdf","provider":"Global Vet \u0026 Co Ltd","version":"1.0","type":"link"}